Publication | Closed Access

Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells––Role of PPAR-γ in vascular fibrosis

InflammationMolecular PharmacologyMolecular PhysiologyMedicineVascular PharmacologyPhysiologyCardiovascular PharmacologyIi-induced Ctgf ExpressionVascular BiologyPharmacotherapyVascular FibrosisPharmacologyCell BiologyCell Signaling